Spark Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SIGAL ELLIOT, was filed 16 Apr 2018.
Spark Therapeutics, Inc.: what insiders have been doing
Spark Therapeutics, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Spark Therapeutics, Inc. in twelve months, the latest record being from 17 December 2019.
Since 2015, the database holds 8 purchases and 182 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
- 38,828 shares@ US$114.5027.3% of flowCommon StockSEC:0000899243-19-029433:0
- 50,193 shares@ US$114.5030.7% of flowCommon StockSEC:0000899243-19-029413:0
- 200 shares@ US$114.500.1% of flowCommon StockSEC:0000899243-19-029413:1
- 28,000 shares@ US$114.50100.0% of flowCommon StockSEC:0000899243-19-029419:0
- 3,000 shares@ US$114.50100.0% of flowCommon StockSEC:0000899243-19-029453:0
- 355,215 shares@ US$114.5099.2% of flowCommon StockSEC:0000899243-19-029435:0
- 3,000 shares@ US$114.50100.0% of flowCommon StockSEC:0000899243-19-029444:0
- 278,834 shares@ US$114.5060.6% of flowCommon StockSEC:0000899243-19-029434:0
- 40,203 shares@ US$114.507.7% of flowCommon StockSEC:0000899243-19-029440:0
- 481,270 shares@ US$114.5092.1% of flowCommon StockSEC:0000899243-19-029440:1
- 12,615 shares@ US$114.5073.1% of flowCommon StockSEC:0000899243-19-029438:0
- 4,134 shares@ US$114.5088.4% of flowCommon StockSEC:0000899243-19-029452:0
- 6,102 shares@ US$114.5092.6% of flowCommon StockSEC:0000899243-19-029449:0
- 3,000 shares@ US$114.50100.0% of flowCommon StockSEC:0000899243-19-029428:0
- 14,214 shares@ US$114.50100.0% of flowCommon StockSEC:0000899243-19-029447:0
- 2,500 shares@ US$114.50100.0% of flowCommon StockSEC:0000899243-19-029446:0
- 8,375 sharesCommon StockSEC:0001609351-19-000064:0
- 2,775 shares@ US$102.3114.1% of flowCommon StockSEC:0001609351-19-000064:1
- 1,500 sharesCommon StockSEC:0001609351-19-000058:0
- 1,500 sharesCommon StockSEC:0001609351-19-000055:0
- 1,500 sharesCommon StockSEC:0001609351-19-000056:0
- 1,500 sharesCommon StockSEC:0001609351-19-000060:0
- 1,500 sharesCommon StockSEC:0001609351-19-000057:0
- 1,500 sharesCommon StockSEC:0001609351-19-000061:0
- 1,500 sharesCommon StockSEC:0001609351-19-000063:0
25 of 375 declarations
About Spark Therapeutics, Inc.
Spark Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapies for rare genetic diseases. It is listed on the NASDAQ under the ticker ONCE.
